Original characteristics and specific protective activity (against the Koch bacillus) of Salvioli's diffusing vaccine
Degli Esposti, A.
La Clinica Pediatrica 52(9): 393-404
1970
ISSN/ISBN: 0009-9058 PMID: 5520735 Document Number: 28030
Document emailed within 1 workday
Related Documents
Rondinini, B. 1965: Trends and Results of Application of Prophylactic Antitubercular Vaccination with the Salvioli's Diffusing Vaccine (S.D.V.) Minerva Medica 56: 1079-1080Lotti, F. 1970: Antitubercular vaccination in Gargagno: report on 10 years of experience with Salvioli's diffusing vaccine La Clinica Pediatrica 52(7): 320-324
Lotti, F. 1970: Evaluation of the allergic and immunological state persons vaccinated at birth with Salvioli's diffusing vaccine La Clinica Pediatrica 52(9): 377-380
Ross, R.F.; Zimmermann-Erickson, B.J.; Young, T.F. 1984: Characteristics of protective activity of Mycoplasma hyopneumoniae vaccine American Journal of Veterinary Research 45(10): 1899-1905
Mendoza, F.; Koch, R. 1983: The discovery of the Koch bacillus Revista Medica de Chile 111(5): 539-543
Mikshis, N.I.; Kudriavtseva, O.M.; Bolothikova, M.F.; Shulepov, D.V.; Novikova, L.V.; Popov, I.A.; Shchukovskaia, T.N.; Drozdov, I.G.; Kutyrev, V.V. 2007: Immunogenicity of the recombinant Bacillus strains with cloned gene of biosynthesis of protective antigen against Bacillus anthracis Molekuliarnaia Genetika Mikrobiologiia i Virusologiia 3: 15-21
Koch, R. 1982: 100 years since the discovery of the tuberculosis bacillus by Robert Koch Revista de Igiena Bacteriologie Virusologie Parazitologie Epidemiologie Pneumoftiziologie. Pneumoftiziologia 31(4): 289-290
Krokhina, M.A.; Apollonin, A.V.; Likhoded, V.G.; Rusanov, V.M.; Sevast'ianova, E.K. 1986: Experimental study of the protective activity of the plasma from donors immunized with an enterobacterial vaccine Gematologiia i Transfuziologiia 31(11): 28-32
Curci, G.; Ninni, A.; Sarappa, A.; D'Antonio, G.; Scognamiglio, S. 1978: Studies of the action of Lipari pumice dust on experimental tuberculosis in guinea pigs and on cultures of Koch bacillus Archivio Monaldi Per la Tisiologia E le Malattie Dell'apparato Respiratorio 33(1-2): 93-102
Carpi Torelli, P.; Tortoli, E. 1980: The use of dodecyl-di(beta-oxyethyl) benzylammonium chloride (Bactofen) as a decontaminant in the cultural examination for detection of the Koch bacillus in sputum Quaderni Sclavo di Diagnostica Clinica E di Laboratorio 16(2): 196-205
Degli Esposti, A. 1970: Appearance of Fong's "protection factor" in animals vaccinated with Savioli's diffusing vaccine La Clinica Pediatrica 52(7): 312-314
Bashkirov, V.I.; Vasil'ev, V.V.; Prozorov, A.A. 1988: Cloning in cells of Bacillus subtilis and study of the characteristics of promoter regions of DNA of Bacillus mesentericus and Phage SPO2 Molekuliarnaia Genetika Mikrobiologiia i Virusologiia 1: 13-20
Mansurova, N.L.; Egorova, N.B.; Kaverina, K.G.; Poliachenko, V.M.; Lobova, E.A. 1991: The specific activity of a multicomponent vaccine made from the antigens of opportunistic microorganisms Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 4: 39-41
Mad'iarova, R.S.; Morogova, V.M. 1974: Use of indirect plaque method for evaluation of the specific activity of antirabies vaccine Voprosy Virusologii 1: 100-103
Vaccari, M.; Poonam, P.; Franchini, G. 2010: Phase IIi HIV vaccine trial in Thailand: a step toward a protective vaccine for HIV Expert Review of Vaccines 9(9): 997-1005
Wheeler, C.M.; Castellsagué, X.; Garland, S.M.; Szarewski, A.; Paavonen, J.; Naud, P.; Salmerón, J.; Chow, S.-N.; Apter, D.; Kitchener, H.; Teixeira, J.úl.C.; Skinner, S.R.; Jaisamrarn, U.; Limson, G.; Romanowski, B.; Aoki, F.Y.; Schwarz, T.F.; Poppe, W.A.J.; Bosch, F.X.; Harper, D.M.; Huh, W.; Hardt, K.; Zahaf, T.; Descamps, D.; Struyf, F.; Dubin, G.; Lehtinen, M.; Denham, I.; Garland, S.M.; Mindel, A.; O'Sullivan, M.; Skinner, S.R.; Waddell, R.; De Sutter, P.; Poppe, W.A.J.; Tjalma, W.; De Carvalho, N.S.; Naud, P.; Teixeira, J.C.; Aoki, F.Y.; Diaz-Mitoma, F.; Dionne, M.; Ferguson, L.; Miller, M.; Papp, K.; Ramjattan, B.; Romanowski, B.; Somani, R.; Apter, D.; Karppa, T.; Kudjoi, N.; Kyha-österlund, L.; Lehtinen, M.; Levanen, H.; Lönn 2012: Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial LANCET. Oncology 13(1): 100-110
Kuvakina, V.I.; Golovina, L.I.; Mishina, A.I.; Skirda, T.A.; Bobyleva, G.V.; Mikheeva, N.G.; Chernyshova, T.F.; Temper, R.M.; Ermolenko, Z.N. 2002: Evaluation of the immunological activity and safety of group B meningococcal vaccine prepared from a natural complex of specific polysaccharide and outer membrane proteins Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2: 33-37
Kent, S.J.; Greenberg, P.D.; Hoffman, M.C.; Akridge, R.E.; McElrath, M.J. 1997: Antagonism of vaccine-induced HIV-1-specific CD4+ T cells by primary HIV-1 infection: potential mechanism of vaccine failure Journal of Immunology 158(2): 807-815
Janse, M.J.; McGuire, M.A.; Loh, P.; Thibault, B.; Hocini, M.; de Bakker, J.M. 1997: Electrical activity in Koch's triangle Canadian Journal of Cardiology 13(11): 1065-1068
Wennerås, C.; Czerkinsky, C.; Svennerholm, A.M. 1995: Vaccine-specific T cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine Advances in Experimental Medicine and Biology 371b: 1641-1644